HD-OPM Archive
Topics › Brain health & dementia

Three repurposed drugs for Alzheimer's: shingles vaccine, sildenafil and riluzole

Louis Nervegna · Feb 21, 2026 · ♥ 15 reactions · 5 comments · original Facebook post
Brain health & dementiaInfections & vaccines
AI summary & key facts

A Delphi consensus led by the University of Exeter reviewed 80 existing medicines and ranked a shingles vaccine, sildenafil and riluzole as top candidates, with good safety and mechanistic plausibility.

Three promising re-purposed drugs for prevention and treatment of Alzheimer’s:

  1. Shingles vaccine (Zostavax)
  2. Viagra (Sildenafil)
  3. The ALS drug Riluzole

Link to full journal paper (November 2025):

Paper · Alzheimers Res Ther · 2025Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation.Conclusion: This Delphi consensus identified three high-priority drug repurposing candidates for AD with favourable safety profiles and mechanistic plausibility, which are considered suitable for pragmatic clinical trials, including remote or hybrid designs. The PROTECT platform, which supports international cohorts in the UK, Norway, and Canada, offers a well-established means to conduct such trials effectively, thupmc.ncbi.nlm.nih.gov

#shinglesvaccineHD #viagraHD #riluzoleHD #vaccinesHD #alzheimersHD #dementiaHD #pde5HD

Research cited

What if the key to slowing Alzheimer’s has been hiding in your medicine cabinet all along?

A new study led by the University of Exeter suggests three familiar drugs a shingles vaccine, Viagra, and a motor neurone disease medication may hold unexpected potential against Alzheimer’s disease. Published in Alzheimer's Research & Therapy and supported by Alzheimer's Society, researchers reviewed 80 existing medicines to see whether any could be repurposed to protect the brain.

For decades, Alzheimer’s research has focused on building new drugs from scratch, a process that can take 10–15 years and billions of dollars. But this international panel of 21 experts asked a different question: what if we already have something that works?

After multiple review rounds, three stood out:

The shingles vaccine emerged as the strongest candidate. It interacts with the immune system, a system increasingly believed to play a central role in Alzheimer’s progression. If future clinical trials confirm the signal, prevention strategies could shift dramatically.

There’s no cure yet. But this approach repurposing safe, widely used medicines, could accelerate progress in ways we haven’t seen before.

If a routine vaccine or common prescription could lower your Alzheimer’s risk, would you want to know and would you take it?

Source: Corbett A, Sultana J, Stych K, et al. Drug repurposing for Alzheimer’s disease: a Delphi consensus and stakeholder consultation. Alzheimer’s Research. 2025.
*image for illustration purposes only

No photo description available.
← newer: p-tau217 blood test raised Alzheimer's diagnostic accuracy tolder: Nuts and colon cancer, content unavailable →